Creating Incentives for Pharmaceutical Research on Neglected Diseases
Edición de la obra Strong medicine
| Autor | Michael Kremer, Rachel Glennerster |
|---|---|
| Editorial | Princeton University Press |
| Fecha de publicación | September 7, 2004 |
| Idioma | inglés |
| Páginas | 152 |
| Formato | Hardcover |
| ISBN-13 | 9780691121130 |
| ISBN-10 | 0691121133 |
| OCLC | 55596208 |
| LCCN | 2004050384 |
| Número de Cutter |
|---|
K92s |
"Vaccines offer the best hope for controlling diseases and could dramatically improve health in poor countries. But developers have little incentive to undertake the costly and risky research needed to develop vaccines. This is partly because the potential consumers are poor, but also because governments drive down prices." "In Strong Medicine, Michael Kremer and Rachel Glennerster offer an innovative yet simple solution to this worldwide problem: "Pull" programs to stimulate research. Here's how such programs would work. Funding agencies would commit to purchase viable vaccines if and when they were developed. This would create the incentives for vaccine developers to produce usable products for these neglected diseases. Private firms, rather than funding agencies, would pick which research strategies to pursue. After purchasing the vaccine, funders could distribute it at little or no cost to the afflicted countries."--BOOK JACKET.